Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support

Chest

Volumn 130, Issue 2, 2006, Pages 334-342

  Tønnesen, Philip ^a   Mikkelsen, Kim ^a   Bremann, Linda ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Behavioral support; COPD; Lung function; Nicotine sublingual tablet; Quality of life; Smoking cessation; Smoking reduction

Indexed keywords

CARBON MONOXIDE; NICOTINE; PLACEBO;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NICOTINE REPLACEMENT THERAPY; NURSE; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING CESSATION; SOCIAL SUPPORT;

EID: 33747621882     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.2.334     Document Type: Article

References (36)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Update of the management sections. NHLBI/WHO Workshop report. Bethesda, MD: National Heart, Lung, and Blood Institute, 2001. Available at: www.goldcopd.com. Accessed March 11, 2006
2. NICE. Chronic obstructive pulmonary disease: National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59(suppl 1):1-232. [www.nice.org.uk/ CG012niceguideline]
3. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guideline. Bockville, MD: U.S. Department of Health and Human Services, Public Health Service, 2000
4. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004; 3:CD000031
5. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; 3:CD000140
6. British Thoracic Society. Comparison of four methods of smoking cessation withdrawal in patients with smoking related diseases. BMJ 1983; 280:595-597
7. Wagena EJ, Knipschild PG, Huibers MJH, et al. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 2005; 165:2286-2292
8. Tashkin DP, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. Lancet 2001; 357:1571-1575
9. Jimenez-Huiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119:1365-1370
10. Hand S, Edwards S, Campbell IA, et al. Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. Thorax 2002; 57:715-718
11. Wagena EJ, van der Meer RM, Ostelo RJ, et al. The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review. Respir Med 2004; 98:805-815
12. Wallström M, Nilsson F, Hirch JM. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 2000; 95:1161-1171
13. Godfredsen NS, Vestbo J, Osler M, et al. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002; 57:967-972
14. Godfredsen NS, Holst C, Prescott E, et al. Smoking reduction, smoking cessation and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 2002; 156:994-1001
15. Bolliger CT, Zellweger JP, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000; 321:329-333
16. Wennike P, Danielsson T, Landfeldt T, et al. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 2003; 98:1395-1402
17. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: Report Working Party Standardization of Lung function Tests, European Community for Steel and Coal; Official Statement of the European Respiratory Society. Eur Respir J 1993; 16(Suppl):5-40
18. Celli BR, Macnee W. ATS/ERS Task Force: standards for the diagnosis and treatment of patients with COPD; a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946
19. Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. BMJ 1980; 281:484-485
20. Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J 1991; 69:763-768
21. Rutten-Van M, Roos B van N. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Disease Questionnaire (CRQ) in a clinical setting. Thorax 1999; 54:995-1003
22. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327
23. Dahl R, Greefhorst LA, Nowark D, et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:778-784
24. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measurement of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581-586
25. Osman IM, Godden DJ, Friend JA, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52:67-71
26. Tønnesen P, Norregaard J, Mikkelsen K, et al. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993; 269:1268-71
27. Tonnesen P, Norregaard J, Simonsen K, et al. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325:311-315
28. 1: the Lung Health Study. JAMA 1994; 272:1497-1505
29. Gorecka D. Nicotine dependence in smokers at risk for COPD [abstract]. Eur Respir J 2002; 20:S134
30. Miloskovic V, Lazic Z. Lung function and level of the smoker's nicotine dependence. Eur Respir J 2001; 18:S115-S116
31. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005; 2:CD001292
32. Tønnesen P, Mikkelsen K, Markholst C, et al. Nurse-conducted smoking cessation in a lung clinic: a randomized controlled study. Eur Respir J 1996; 9:2351-2355
33. Tønnesen P, Mikkelsen K. Smoking cessation with four nicotine replacement regimes in a lung clinic. Eur Respir J 2000; 16:717-722
34. Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling by health care providers. Cancer Epidemiol Biomarkers Prev 2004; 13:2012-2022
35. Rice VH, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev 2004; 1:CD001188
36. 1: results from the Lung Health Study. Eur Respir J 2005; 25:1011-1017